Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy

Creative Commons License

Topkan E., Parlak C., Kotek A., Yapar A. F., Pehlivan B.

BMC GASTROENTEROLOGY, vol.11, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11
  • Publication Date: 2011
  • Doi Number: 10.1186/1471-230x-11-123
  • Journal Name: BMC GASTROENTEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: Concurrent chemoradiotherapy, locally advanced pancreas cancer, positron emission tomography, metabolic response, clinical outcome prediction, POSITRON-EMISSION-TOMOGRAPHY, F-18 FLUORODEOXYGLUCOSE, FDG-PET, STEREOTACTIC RADIOSURGERY, DIFFERENTIAL-DIAGNOSIS, COMPUTED-TOMOGRAPHY, RADIATION-THERAPY, LUNG-CANCER, GEMCITABINE, CT
  • Akdeniz University Affiliated: Yes

Abstract

Background: We aimed to study the predictive value of combined 18F-fluoro-deoxy-D-glucose positron emission tomography and computerized tomography (FDG-PET-CT), on outcomes in locally advanced pancreatic carcinoma (LAPC) patients treated with concurrent chemoradiotherapy (C-CRT).